RetinalGenix Technologies (RTGN) Total Current Liabilities (2023 - 2026)

RetinalGenix Technologies has disclosed Total Current Liabilities across 4 years of filings, most recently posting $2.6 million for Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $2.6 million, up 53.02% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.6 million (up 53.02% YoY), and the FY2025 annual result was $2.3 million, up 57.71% from the prior year.
• Total Current Liabilities came in at $2.6 million for Q1 2026 at RetinalGenix Technologies, up from $2.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $2.6 million in Q1 2026 to a low of $1.4 million in Q4 2023.
• The 4-year median for Total Current Liabilities is $2.0 million (2024), against an average of $1.9 million.
• Across the five-year window, Total Current Liabilities rose 4.64% in 2024 and jumped 57.71% in 2025, its largest moves.
• RetinalGenix Technologies' Total Current Liabilities stood at $1.4 million in 2023, then increased by 4.64% to $1.5 million in 2024, then surged by 57.71% to $2.3 million in 2025, then increased by 10.38% to $2.6 million in 2026.
• The last three Total Current Liabilities figures came in at $2.6 million (Q1 2026), $2.3 million (Q4 2025), and $2.2 million (Q3 2025), per Business Quant data.